Invited commentary: Retroperitoneal and visceral sarcomas: Issues for the general surgeon

American Surgeon

Volumn 73, Issue 6, 2007, Pages 631-635

  Woodall, Charles E ^a   Scoggins, Charles R ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; DIGESTIVE SYSTEM CANCER; FOLLOW UP; GENERAL SURGERY; INTESTINE BIOPSY; METASTASIS; NOTE; RETROPERITONEAL SARCOMA; TREATMENT OUTCOME; VISCERAL SARCOMA; ABDOMINAL TUMOR; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; GASTROINTESTINAL STROMAL TUMOR; HUMAN; RETROPERITONEAL TUMOR; REVIEW; SARCOMA;

ABDOMINAL NEOPLASMS; CHEMOTHERAPY, ADJUVANT; GASTROINTESTINAL STROMAL TUMORS; HUMANS; RADIOTHERAPY, ADJUVANT; RETROPERITONEAL NEOPLASMS; SARCOMA;

EID: 34548577159     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (45)

1. Wells G, Martin RC, McMasters KM, Scoggins CR. Soft tissue sarcoma of the extremity and trunk: Issues for the general surgeon. Am Surg 2006;72:665-71.
2. DeVita VT Jr., Hellman S, Rosenburg SA. Cancer: Principles and Practice of Oncology. Philadelphia, PA: Lippincott, Williams & Wilkins, 2001.
3. Catton CN, O'Sullivan B, Kotwall C, et al. Outcome and prognosis in retroperitoneal soft tissue sarcoma. Int J Radiat Oncol Biol Phys 1994;29:1005-10.
4. Pisters P. Soft Tissue Sarcomas. Hamilton, London: BC Decker, Inc., 2002.
5. Lewis JJ, Leung D, Woodruff JM, Brennan MF. Retroperitoneal soft-tissue sarcoma: Analysis of 500 patients treated and followed at a single institution. Ann Surg 1998;228:355-65.
6. American Cancer Society. Cancer Facts and Figures, 2006. 2006, pp 1-58.
7. Miettinen M, Sobin LH, Sarlomo-Rikala M. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT). Mod Pathol 2000;13:1134-42.
8. Miettinen M, Lasota J. Gastrointestinal stromal tumors: Definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 2001;438:1-12.
9. Russo P, Kim Y, Ravindran S, et al. Nephrectomy during operative management of retroperitoneal sarcoma. Ann Surg Oncol 1997;4:421-4.
10. Ferrario T, Karakousis CP. Retroperitoneal sarcomas: Grade and survival. Arch Surg 2003;138:248-51.
11. Chiappa A, Zbar AP, Biffi R, et al. Primary and recurrent retroperitoneal sarcoma: Factors affecting survival and long-term outcome. Hepatogastroenterology 2004;51:1304-9.
12. Hassan I, Park SZ, Donohue JH, et al. Operative management of primary retroperitoneal sarcomas: A reappraisal of an institutional experience. Ann Surg 2004;239:244-50.
13. Shibata D, Lewis JJ, Leung DH, Brennan MF. Is there a role for incomplete resection in the management of retroperitoneal liposarcomas? J Am Coll Surg 2001;193:373-9.
14. Karakousis CP, Gerstenbluth R, Kontzoglou K, Driscoll DL. Retroperitoneal sarcomas and their management. Arch Surg 1995;130:1104-9.
15. Dalton RR, Donohue JH, Mucha P Jr, et al. Management of retroperitoneal sarcomas. Surgery 1989;106:725-32.
16. Alvarenga JC, Ball AB, Fisher C, et al. Limitations of surgery in the treatment of retroperitoneal sarcoma. Br J Surg 1991;78:912-6.
17. Kilkenny JW III, Bland KI, Copeland EM III. Retroperitoneal sarcoma: The University of Florida experience. J Am Coll Surg 1996;182:329-39.
18. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual, 6th ed. New York, Springer, 2002.
19. Bevilacqua RG, Rogatko A, Hajdu SI, Brennan MF. Prognostic factors in primary retroperitoneal soft-tissue sarcomas. Arch Surg 1991;126:328-34.
20. Cody HS III, Turnbull AD, Fortner JG, Hajdu SI. The continuing challenge of retroperitoneal sarcomas. Cancer 1981;47:2147-52.
21. van Dalen T, Hennipman A, Van Coevorden F, et al. Evaluation of a clinically applicable post-surgical classification system for primary retroperitoneal soft-tissue sarcoma. Ann Surg Oncol 2004;11:483-90.
22. Suit HD, Russell WO, Martin RG. Management of patients with sarcoma of soft tissue in an extremity. Cancer 1973;31:1247-55.
23. Pisters PW, Leung DH, Woodruff J, et al. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 1996;14:1679-89.
24. Pisters PW, Harrison LB, Leung DH, et al. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 1996;14:859-68.
25. Yang JC, Chang AE, Baker AR, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 1998;16:197-203.
26. Zagars GK, Ballo MT, Pisters PW, et al. Preoperative vs. postoperative radiation therapy for soft tissue sarcoma: A retrospective comparative evaluation of disease outcome. Int J Radiat Oncol Biol Phys 2003;56:482-8.
27. Zagars GK, Ballo MT. Sequencing radiotherapy for soft tissue sarcoma when re-resection is planned. Int J Radiat Oncol Biol Phys 2003;56:21-7.
28. Harrison LB, Gutierrez E, Fischer JJ. Retroperitoneal sarcomas: The Yale experience and a review of the literature. J Surg Oncol 1986;32:159-64.
29. Tepper JE, Suit HD, Wood WC, et al. Radiation therapy of retroperitoneal soft tissue sarcomas. Int J Radiat Oncol Biol Phys 1984;10:825-30.
30. Pisters PW, Ballo MT, Fenstermacher MJ, et al. Phase I trial of preoperative concurrent doxorubicin and radiation therapy, surgical resection, and intraoperative electron-beam radiation therapy for patients with localized retroperitoneal sarcoma. J Clin Oncol 2003;21:3092-7.
31. Robertson JM, Sondak VK, Weiss SA, et al. Preoperative radiation therapy and iododeoxyuridine for large retroperitoneal sarcomas. Int J Radiat Oncol Biol Phys 1995;31:87-92.
32. Sarcoma Meta-analysis Collaboration. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: Meta-analysis of individual data. Lancet 1997;350:1647-54.
33. Frustaci S, Gherlinzoni F, De Paoli A, et al. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: Results of the Italian randomized cooperative trial. J Clin Oncol 2001;19:1238-47.
34. Cormier JN, Huang X, Xing Y, et al. Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: Chemotherapy-associated outcomes. J Clin Oncol 2004;22:4567-74.
35. Wu TJ, Lee LY, Yeh CN, et al. Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: Before the era of imatinib mesylate. BMC Gastroenterol 2006;6:29.
36. Gold JS, van der Zwan SM, Gonen M, et al. Outcome of metastatic GIST in the era before tyrosine kinase inhibitors. Ann Surg Oncol 2007;14(1):134-42.
37. Gupta M, Sheppard BC, Corless CL, et al. Outcome following surgical therapy for gastrointestinal stromal tumors. J Gastrointest Surg 2006;10:1099-105.
38. Rutkowski P, Nowecki Z, Nyckowski P, et al. Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate. J Surg Oncol 2006;93:304-11.
39. Bauer S, Lang H, Schutte J, Hartmann JT. Complete remission with imatinib in metastatic gastrointestinal stromal tumors. J Clin Oncol 2005;23:6800-1.
40. Bauer S, Hartmann JT, de Wit M, et al. Resection of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment with imatinib. Int J Cancer 2005;117:316-25.
41. Kane JM III. Surveillance strategies for patients following surgical resection of soft tissue sarcomas. Curr Opin Oncol 2004;16:328-32.
42. Putnam JB Jr, Roth JA, Wesley MN, et al. Analysis of prognostic factors in patients undergoing resection of pulmonary metastases from soft tissue sarcomas. J Thorac Cardiovasc Surg 1984;87:260-8.
43. Jablons D, Steinberg SM, Roth J, et al. Metastasectomy for soft tissue sarcoma. Further evidence for efficacy and prognostic indicators. J Thorac Cardiovasc Surg 1989;97:695-705.
44. Whooley BP, Mooney MM, Gibbs JF, Kraybill WG. Effective follow-up strategies in soft tissue sarcoma. Semin Surg Oncol 1999;17:83-7.
45. DeMatteo RP, Shah A, Fong Y, et al. Results of hepatic resection for sarcoma metastatic to liver. Ann Surg 2001;234:540-7.